Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of “eye stroke” (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published in the British Journal of Ophthalmology.
Source link
Wegovy may have highest 'eye stroke' and sight loss risk among semaglutide GLP-1 agonists
March 10, 2026
0 Comments
Explore More
AI tool uses eye imaging datasets to optimize diabetic eye screening
Deep learning system training schema for the 2 year prediction interval. Credit: Communications Medicine (2024). DOI: 10.1038/s43856-024-00590-z Researchers at King’s College London have used anonymized NHS eye data from more
Eye drops derived from PEDF protein slow vision loss in animal models
Model of PEDF protein alongside the 17-mer and H105A peptides. Amino acid 105, which is changed from histidine in PEDF and the 17-mer peptide to alanine in the H105A peptide,
Laser eye treatment shows potential for halting dry macular degeneration progression in animal models
Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD). Credit: Matti Ahlgren / Aalto University Around a third of people over the age